Regulus Therapeutics Eulerpool Novinky

Regulus Therapeutics Novinky o akciách

Regulus Therapeutics sledujú mnohí novinári a investori po celom svete. Najaktuálnejšie správy Regulus Therapeutics zhromažďujeme práve tu.

• 8. decembra ·

  Yahoo
  With 64% institutional ownership, Regulus Therapeutics Inc. (NASDAQ:RGLS) is a favorite amongst the big guns
• 26. novembra ·

  Yahoo
  Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences
• 7. novembra ·

  Yahoo
  Regulus: Q3 Earnings Snapshot
• 7. novembra ·

  Yahoo
  Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates
• 1. novembra ·

  TipRanks
  Biotech Alert: Searches spiking for these stocks today
• 30. októbra ·

  TipRanks
  Positive Buy Rating for Regulus Therapeutics Driven by Promising Phase 1b Results and Strategic Patent Agreement
• 29. októbra ·

  Yahoo
  These 2 ‘Strong Buy’ Penny Stocks Could Rally Over 500%, Say Analysts
• 28. októbra ·

  TipRanks
  These 2 ‘Strong Buy’ Penny Stocks Could Rally Over 500%, Say Analysts
• 9. októbra ·

  TipRanks
  Buy Rating Affirmed for Regulus Amid Promising miRNA Therapy Advances for ADPKD
• 8. októbra ·

  Yahoo
  Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)